Replies to post #20266 on MindMaze Therapeutics Holding (RLFTF)

[PennyWorld]

Whala... thanks for the expanded clarification!

[Millstone]

The current IV trial of Aviptadil is a Phase II/III. It is a registration trial and a COMBINED Phase 2 and 3, meaning at the trials end in 3-4 weeks, it will be the end of the PHASE 3.

No doubt and EUA will be applied for (and granted), and FDA will follow with a full approval.

This release from NeuroRx confirms that the intravenous Aviptadil trial includes Phase 3: https://www.neurorxpharma.com/press-releases/press-release-phase2-3covid-19/